Health Boards
Fri-03-02-2017, 19:04 PM
This is the first study report I have read and although I do not understand much of it I am astonished by the comment.
Subcutaneous methotrexate was generally well tolerated; no patients died or had serious infections, malignancies, or major adverse cardiovascular events. Serious adverse events were recorded in three (3%) patients who received methotrexate for the full 52 week treatment period.
OK nobody died! Was that a potential outcome!
I have just started on subcut MTX and will give it a few months to see how it improves things.
My consultant suggests the same dosage using subcut MTX has an absorption of about 90% against 60% for oral so should be more effective. I only have a few small patches that have crept back but knowing there is an opportunity to clear my psoriasis I will take it. As with any medication I accept there are risks. Fortunately I have had zero side effects but if it continues to return will need another alternative.
Subcutaneous methotrexate was generally well tolerated; no patients died or had serious infections, malignancies, or major adverse cardiovascular events. Serious adverse events were recorded in three (3%) patients who received methotrexate for the full 52 week treatment period.
OK nobody died! Was that a potential outcome!
I have just started on subcut MTX and will give it a few months to see how it improves things.
My consultant suggests the same dosage using subcut MTX has an absorption of about 90% against 60% for oral so should be more effective. I only have a few small patches that have crept back but knowing there is an opportunity to clear my psoriasis I will take it. As with any medication I accept there are risks. Fortunately I have had zero side effects but if it continues to return will need another alternative.
